|
JNJ-26854165 (Serdemetan)
|
S126246-10mg
|
≥98% |
881202-45-5 |
10mg
|
¥ 575.9
|
现货 |
|
0 |
阿拉丁 |
|
INF 4E,半胱天冬酶-1和NLRP3炎性体抑制剂
|
I288937-5mg
|
≥98%(HPLC) |
88039-46-7 |
5mg
|
¥ 60.9
|
现货 |
|
0 |
阿拉丁 |
|
INF 4E,半胱天冬酶-1和NLRP3炎性体抑制剂
|
I288937-50mg
|
≥98%(HPLC) |
88039-46-7 |
50mg
|
¥ 146.9
|
现货 |
|
0 |
阿拉丁 |
|
INF 4E,半胱天冬酶-1和NLRP3炎性体抑制剂
|
I288937-25mg
|
≥98%(HPLC) |
88039-46-7 |
25mg
|
¥ 109.9
|
现货 |
|
0 |
阿拉丁 |
|
INF 4E,半胱天冬酶-1和NLRP3炎性体抑制剂
|
I288937-100mg
|
≥98%(HPLC) |
88039-46-7 |
100mg
|
¥ 196.9
|
现货 |
|
0 |
阿拉丁 |
|
布罗曼坦
|
B355166-1g
|
≥98% |
87913-26-6 |
1g
|
¥ 3089.9
|
现货 |
|
0 |
阿拉丁 |
|
布罗曼坦
|
B355166-25mg
|
≥98% |
87913-26-6 |
25mg
|
¥ 308.9
|
现货 |
|
0 |
阿拉丁 |
|
布罗曼坦
|
B355166-250mg
|
≥98% |
87913-26-6 |
250mg
|
¥ 1338.9
|
现货 |
|
0 |
阿拉丁 |
|
布罗曼坦
|
B355166-100mg
|
≥98% |
87913-26-6 |
100mg
|
¥ 720.9
|
现货 |
|
0 |
阿拉丁 |
|
EGFR抑制剂
|
E337818-5mg
|
Moligand™, ≥98% |
879127-07-8 |
5mg
|
¥ 1018.9
|
现货 |
|
0 |
阿拉丁 |
|
EGFR抑制剂
|
E337818-25mg
|
Moligand™, ≥98% |
879127-07-8 |
25mg
|
¥ 2779.9
|
现货 |
|
0 |
阿拉丁 |
|
EGFR抑制剂
|
E337818-100mg
|
Moligand™, ≥98% |
879127-07-8 |
100mg
|
¥ 7414.9
|
现货 |
|
0 |
阿拉丁 |
|
Walrycin B
|
W412232-25mg
|
Moligand™, ≥98% |
878419-78-4 |
25mg
|
¥ 1043.9
|
现货 |
|
0 |
阿拉丁 |
|
Walrycin B
|
W412232-100mg
|
Moligand™, ≥98% |
878419-78-4 |
100mg
|
¥ 3969.9
|
现货 |
|
0 |
阿拉丁 |
|
2-氯-N-(噻吩-2-基甲基)丙酰胺
|
C356024-5g
|
≥95% |
878125-78-1 |
5g
|
¥ 9792.9
|
现货 |
|
0 |
阿拉丁 |
|
(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二[2,4,6-三(1-甲基乙基)苯基]-二萘并[2,1-d:1',2'-f][1,3,2]二氧杂磷杂卓 4-氧化物
|
B300943-25mg
|
≥98% |
878111-20-7 |
25mg
|
¥ 302.9
|
现货 |
|
0 |
阿拉丁 |
|
(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二[2,4,6-三(1-甲基乙基)苯基]-二萘并[2,1-d:1',2'-f][1,3,2]二氧杂磷杂卓 4-氧化物
|
B300943-250mg
|
≥98% |
878111-20-7 |
250mg
|
¥ 1103.9
|
现货 |
|
0 |
阿拉丁 |
|
(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二[2,4,6-三(1-甲基乙基)苯基]-二萘并[2,1-d:1',2'-f][1,3,2]二氧杂磷杂卓 4-氧化物
|
B300943-1g
|
≥98% |
878111-20-7 |
1g
|
¥ 3752.9
|
现货 |
|
0 |
阿拉丁 |
|
(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二[2,4,6-三(1-甲基乙基)苯基]-二萘并[2,1-d:1',2'-f][1,3,2]二氧杂磷杂卓 4-氧化物
|
B300943-100mg
|
≥98% |
878111-20-7 |
100mg
|
¥ 504.9
|
现货 |
|
0 |
阿拉丁 |
|
1-[3-(二甲基氨基)丙基]哌嗪
|
D344388-5g
|
≥97% |
877-96-3 |
5g
|
¥ 488.9
|
现货 |
|
0 |
阿拉丁 |
|
TW-37,小分子BCL-2抑制剂
|
T127475-5mg
|
≥98% |
877877-35-5 |
5mg
|
¥ 586.9
|
现货 |
|
0 |
阿拉丁 |
|
TW-37,小分子BCL-2抑制剂
|
T127475-100mg
|
≥98% |
877877-35-5 |
100mg
|
¥ 4075.9
|
现货 |
|
0 |
阿拉丁 |
|
KG 5,PDGFRβ,B-Raf,c-Raf,FLT3和KIT抑制剂
|
K288441-5mg
|
≥98%(HPLC) |
877874-85-6 |
5mg
|
¥ 1157.9
|
现货 |
|
0 |
阿拉丁 |
|
KG 5,PDGFRβ,B-Raf,c-Raf,FLT3和KIT抑制剂
|
K288441-25mg
|
≥98%(HPLC) |
877874-85-6 |
25mg
|
¥ 3706.9
|
现货 |
|
0 |
阿拉丁 |